Form 4 for IDXX Idexx Laboratories
Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0000874716-24-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-16 | 2024-02-14 | IDXX | FENNELL GEORGE | SVP, Chief Revenue Off | M - OptEx | $0.00 | +370 | 6,820 | +6% | $0 |
| D | 2024-02-16 | 2024-02-14 | IDXX | FENNELL GEORGE | SVP, Chief Revenue Off | F - Tax | $560.56 | -162 | 6,920 | -2% | -$90.8K |
| DM | 2024-02-16 | 2024-02-14 | IDXX | FENNELL GEORGE | SVP, Chief Revenue Off | M - OptEx | $0.00 | -370 | 51 | -88% | $0 |
| DM | 2024-02-16 | 2024-02-14 | IDXX | FENNELL GEORGE | SVP, Chief Revenue Off | A - Grant | $0.00 | +3,143 | 2,408 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-14 | M | A | 57 | $0.00 | 7,082 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-14 | M | A | 56 | $0.00 | 7,025 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-14 | M | A | 52 | $0.00 | 6,969 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-14 | M | A | 97 | $0.00 | 6,917 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-14 | M | A | 108 | $0.00 | 6,820 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-14 | F | D | 162 | $560.56 | 6,920 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 56 | $0.00 | 111 | D | — · — to — | 56 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning ion February 14, 2023. |
| 8 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 57 | $0.00 | 169 | D | — · — to — | 57 Common Stock | (F8) Each RSU represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2024. |
| 9 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 97 | $0.00 | 0 | D | — · — to — | 97 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments beginning on February 14, 2021. |
| 10 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 108 | $0.00 | 0 | D | — · — to — | 108 Common Stock | (F4) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in five annual installments beginning on February 14, 2020. |
| 11 | Derivative | Restricted Stock Unit | 2024-02-14 | A | A | 557 | $0.00 | 557 | D | — · — to — | 557 Common Stock | (F3) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025. |
| 12 | Derivative | Incentive Stock Option (right-to-buy) | 2024-02-14 | A | A | 178 | $0.00 | 178 | D | $560.56 · — to 2034-02-13 | 178 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028. |
| 13 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2024-02-14 | A | A | 2,408 | $0.00 | 2,408 | D | $560.56 · — to 2034-02-13 | 2,408 Common Stock | (F1) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025. |
| 14 | Derivative | Restricted Stock Unit | 2024-02-14 | M | D | 52 | $0.00 | 51 | D | — · — to — | 52 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer. common stock and vest in four annual installments beginning on February 14, 2022. |